Riskpilot← Back to searchSign inGet full accessGAIAFJELL AS
ASActiveOrg 974540800Sjølyst Plass 2, 0278 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 19950 employees
Revenue 2024
NOK 0
EBITDA margin
—
-136% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK 4K
+758% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -1K | -136% |
| Net profit | NOK 4K | +758% |
| Total assets | NOK 323K | +1% |
| Equity | NOK 323K | +1% |
| Employees | 0 | — |
Legal name
GAIAFJELL AS
Org number
974540800
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26. juni 1995
Share capital
NOK 150 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Næringsvirksomhet samt enhver virksomhet som står i forbindelse med dette. Herunder investeringer i og utvikling av fast eiendom og deltagelse i andre selskaper ved aksjeinnskudd eller på annen måte.
Address
Sjølyst Plass 2, 0278 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −1 | 11 | −1 | −1 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 | 11 | −1 | −1 | −1 |
| Net financials | 4 | 0 | 0 | 0 | 5 |
| Profit before tax | 3 | 11 | −1 | −1 | 4 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 3 | 11 | −1 | −1 | 4 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 320 | 320 | 319 | 319 | 323 |
| Equity | 309 | 320 | 319 | 319 | 323 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12 | 0 | 0 | 0 | 0 |
| Total debt | 12 | 0 | 0 | 0 | 0 |
EBITDA margin
-141500.0%
This company
15.8%
Market median
-895670% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
20202024
Net profit margin
395000.0%
This company
8.1%
Market median
+4876443% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HØ Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
EN Deputy Member | Deputy Member | 2006 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hennord Invest As
GAIAFJELL AS Board members of GAIAFJELL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ellen Nordvik | Deputy Member | 0 companies |
| Hans Øivind Nordvik | Chief Executive Officer | 0 companies |
| Henrik Nordvik | Board of Directors | 0 companies |
| Hans Christian Nordvik | Board of Directors | 0 companies |